

share
Eburnamenine CAS NO 517-30-6
Unit Price:
CAS No.:517-30-6
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Eburnamenine CAS NO 517-30-6 is a naturally occurring indole alkaloid of significant interest in pharmaceutical research and development. This compound serves as a crucial intermediate and reference standard for the synthesis and study of more complex bioactive molecules. It is primarily utilized by research institutions, pharmaceutical companies, and fine chemical manufacturers engaged in neuroscience and medicinal chemistry. Its well-defined structure makes it a valuable tool for analytical and synthetic applications.
Application
- Pharmaceutical Intermediate: A key building block in the research and synthesis of novel therapeutic agents targeting the central nervous system.
- Reference Standard: Used as a high-purity standard in analytical chemistry for method development, validation, and quality control (QC/QA) of related alkaloids.
- Medicinal Chemistry Research: Employed in structure-activity relationship (SAR) studies to explore and optimize biological activity profiles.
- Biochemical Research: Utilized as a tool compound in pharmacological assays and studies of neurological pathways.
- Fine Chemical Synthesis: Serves as a starting material or intermediate for the custom synthesis of specialized chemicals and derivatives.
Basic Information
| Product Name | Eburnamenine |
| CAS No. | 517-30-6 |
| Molecular Formula | C19H22N2 |
| Molecular Weight | 278.39 g/mol |
| Synonyms | Eburnamenine; (-)-Eburnamenine; (19S)-Eburnamenine; 19,20-Didehydroeburnamenine; Vincamajoridine; Eburnamennine; Eburnamonine; 1,2-Didehydroaspidospermidine |
| EINECS | Contact for details |
Quality Control
Our Eburnamenine is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity suitable for research applications. Each lot undergoes comprehensive analysis, including identity confirmation by spectroscopic methods and purity determination by chromatographic techniques. A Certificate of Analysis (COA) detailing all test results is provided with every shipment to support your regulatory and quality assurance requirements.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container sealed to protect from moisture and contamination.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (IR) | Conforms to reference spectrum |
| Identification (HPLC) | Retention time matches reference standard |
| Purity (HPLC) | ≥ 98.0% |
| Loss on Drying | ≤ 0.5% |
| Residue on Ignition | ≤ 0.1% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Rutaecarpine CAS NO 84-26-4


1,7-Dimethylxanthine CAS NO 611-59-6


Capsaicin CAS NO 404-86-4


Muscimol Hydrate CAS NO 18174-72-6


Catharanthine CAS NO 2468-21-5


Muscimol CAS NO 2763-96-4


6-Methoxyharmalan CAS NO 3589-73-9


Mesembrine CAS NO 468-53-1


Dihydroberberine CAS NO 483-15-8


Nicotine CAS NO 54-11-5


Quinine Hydrochloride Dihydrate CAS NO 6119-47-7


Arecoline CAS NO 63-75-2


Tetrahydropapaverine Hydrochloride CAS NO 6429-04-5


L-Hyoscyamine CAS NO 101-31-5


14,17-Dihydro-3-Methoxy-16(15H)-Oxaerythrinan-15-One (3Beta)- CAS NO 115-36-6


Sinomenine CAS NO 115-53-7


Benzog-1,3-Benzodioxolo5,6-Aquinolizinium, 5,6-Dihydro-9,10-Dimethoxy-, Hydroxide CAS NO 117-74-8


Cinchonine CAS NO 118-10-5


Sabadine CAS NO 124-80-1


Protoveratrine B CAS NO 124-97-0
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






